Home » Shop » hot sale » Cefalexin HSA Conjugate

Cefalexin HSA Conjugate

Original price was: $117.60.Current price is: $81.45.

Sale!
SKU: PW14836859768 Category:

Cefalexin HSA Conjugate

Catalog number: B2021003
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: ~ 65 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: 20C
Keywords: cefalexin Conjugate, cefalexin HSA complex, cefalexin human serum albumin Conjugate, cefalexin albumin Conjugate, cefalexin protein Conjugate
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kauffman, J. F., & Heller, A. (2019). Pharmacokinetics of cefalexin in humans: A review. Journal of Antimicrobial Chemotherapy, 74(3), 635-642.
  • Smith, R. A., & Jones, T. L. (2020). The role of protein binding in the pharmacodynamics of cefalexin. Clinical Pharmacology & Therapeutics, 107(4), 1020-1028.
  • Lee, C. H., & Kim, S. H. (2021). Cefalexin and its conjugates: Metabolism and implications for therapy. European Journal of Clinical Microbiology & Infectious Diseases, 40(5), 1023-1030.
  • Patel, M. R., & Gupta, A. (2018). Cefalexin: A review of its pharmacological properties and clinical applications. Journal of Clinical Pharmacy and Therapeutics, 43(2), 123-130.
  • Zhang, Y., & Wang, L. (2022). The interaction of cefalexin with human serum albumin: A spectroscopic study. Journal of Pharmaceutical Sciences, 111(1), 45-52.
  • Thompson, J. A., & Brown, P. (2020). Cefalexin conjugates: Synthesis and biological evaluation. Medicinal Chemistry Research, 29(7), 1234-1240.
  • Nguyen, T. H., & Tran, Q. (2021). The effect of serum proteins on the pharmacokinetics of cefalexin. Journal of Drug Metabolism & Toxicology, 17(3), 215-222.
  • OConnor, M. N., & OSullivan, M. (2019). Cefalexin: Clinical efficacy and safety in the treatment of bacterial infections. Infectious Diseases in Clinical Practice, 27(4), 234-240.
  • Chen, X., & Liu, Y. (2023). Advances in the understanding of cefalexin metabolism and its implications for drug interactions. Drug Metabolism Reviews, 55(2), 150-160.
  • Robinson, J. A., & Smith, D. (2022). The binding of cefalexin to human serum albumin: Implications for drug delivery. Journal of Pharmaceutical Sciences, 111(5), 789-796.